Acadia Pharmaceuticals Inc

Acadia Pharmaceuticals Inc

ACAD

Market Cap$3.33B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Acadia Pharmaceuticals IncAcadia Pharmaceuticals Inc25.9-22%3.90.1
$20.00

Target Price by Analysts

1.3% upsideAcadia Pharmaceuticals Target Price DetailsTarget Price
$18.95

Current Fair Value

4% downside

Overvalued by 4% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.33 Billion
Enterprise Value$3.22 Billion
Dividend Yield$0 (0%)
Earnings per Share$-0.37
Beta0.37
Outstanding Shares165,974,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio25.88
PEG-17.22
Price to Sales3.95
Price to Book Ratio6.58
Enterprise Value to Revenue3.46
Enterprise Value to EBIT28.69
Enterprise Value to Net Income25
Total Debt to Enterprise0.01
Debt to Equity0.07

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Acadia Pharmaceuticals Inc

CEO: Uli Hacksell